A
ALMS
Alumis Inc
21.89
-0.28-1.26%Opening15:51 05/22 EDT
OPEN/PREV CLOSE22.25/22.17
TODAY RANGE21.73-22.72
VOL325.76K
MARKET CAP2.79B
52 WEEK RANGE2.760-30.60
AVG VOL (3M)1.33M
% TURNOVER0.26%
TURNOVER--
P/E (TTM)-11.3927
% RANGE4.47%
EPS(TTM)-1.9214
P/E(FORWARD)-7.5483
P/B4.912
BVPS4.457
DIVIDEND--
P/S95.30
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.90B
SHARES OUTSTANDING127.49M
NEXT EARNINGS08/11-08/17
FREE FLOAT86.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·3d ago
Alumis Is Maintained at Buy by Chardan Capital
TipRanks·3d ago
Alumis price target raised to $40 from $38 at Chardan
PUBT·3d ago
Alumis announces annual shareholder meeting
Simply Wall St·4d ago
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Envudeucitinib Data And Upcoming Regulatory Milestones
Simply Wall St·6d ago
Should Alumis’ (ALMS) Envudeucitinib-Centric Strategy After Q1 Losses Require Action From Investors?
Benzinga·05/15 15:49
This Unity Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
TipRanks·05/15 15:26
Alumis Inc. (ALMS) Gets a Buy from Leerink Partners
Dow Jones·05/15 13:14
Alumis Is Maintained at Overweight by Wells Fargo
Benzinga·05/15 13:03
Wells Fargo Maintains Overweight on Alumis, Raises Price Target to $51
Dow Jones·05/15 12:58
Alumis Is Maintained at Buy by Guggenheim
Dow Jones·05/15 12:58
Alumis Price Target Raised to $34.00/Share From $32.00 by Guggenheim
TipRanks·05/15 12:49
Alumis price target raised to $39 from $38 at Morgan Stanley
Benzinga·05/15 12:48
Guggenheim Maintains Buy on Alumis, Raises Price Target to $34
Same Industry
Name/Symbol
Change%
Price